Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Laboratory Analytical Instruments

Bionano Genomics, Inc. to acquire Purigen

Announced Nov 28, 2022 · Closed Nov 30, 2022 · Private target

Deal value$32M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash

Transaction

Acquirer
Bionano Genomics, Inc. (BNGO)
Target
Purigen
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Nov 30, 2022

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
TD Cowen
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Laboratory Analytical Instruments
Sources
  • 8-K (EX-99.1) · Nov 28, 2022

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.